In our issue of September 18, we discussed the use of vasoconstrictor drugs in myocardial infarction (Drug Ther. Bull. p. 73), pointing out the theoretical reasons for doubting their advisability, though many clinicians think that noradrenaline is of value. Since then two papers have appeared which reinforce our arguments.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.